Found: 12
Select item for more details and to access through your institution.
Management of front line chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, p. S3, doi. 10.1002/ajh.26677
- By:
- Publication type:
- Article
Management of front line chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, p. S3, doi. 10.1002/ajh.26677
- By:
- Publication type:
- Article
Health‐related quality of life with fixed‐duration venetoclax‐obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trial.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. 1112, doi. 10.1002/ajh.26260
- By:
- Publication type:
- Article
Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL).
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. 1002, doi. 10.1002/ajh.25561
- By:
- Publication type:
- Article
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e498, doi. 10.1016/j.clml.2022.01.007
- By:
- Publication type:
- Article
Economic evaluation of chronic lymphocytic leukemia from a hospital management perspective.
- Published in:
- European Journal of Haematology, 2017, v. 98, n. 2, p. 169, doi. 10.1111/ejh.12817
- By:
- Publication type:
- Article
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1361, doi. 10.1007/s00259-023-06554-0
- By:
- Publication type:
- Article
Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-03170-7
- By:
- Publication type:
- Article
Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms.
- Published in:
- Biomarker Insights, 2015, v. 10, p. 15, doi. 10.4137/BMI.S22434
- By:
- Publication type:
- Article
Specialized palliative care in patients with haematological malignancies receiving chimeric antigen receptor T‐cell therapy.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 343, doi. 10.1111/bjh.19434
- By:
- Publication type:
- Article
Fludarabine, cyclophosphamide, and rituximab as first‐line treatment in patients with chronic lymphocytic leukemia: A long‐term analysis of the German CLL Study Group (GCLLSG) registry.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 2, p. 235, doi. 10.1111/ejh.14220
- By:
- Publication type:
- Article
Long‐term remission in a patient with relapsed Richter's transformation treated with CD19‐directed chimeric antigen‐receptor T‐cells after allogeneic stem cell transplantation.
- Published in:
- 2024
- By:
- Publication type:
- Case Study